Détail de l'auteur
Auteur Vuillerot C |
Documents disponibles écrits par cet auteur



![]()
Responsiveness and Minimal Clinically Important Difference of the Motor Function Measure in collagen VI-related dystrophies (COL6-RD) and laminin alpha2-related muscular dystrophy (LAMA2-RD)
Le Goff L, Meilleur KG, Norato G, et al.
Archives of physical medicine and rehabilitation, 2020
Revue : Archives of physical medicine and rehabilitation Titre : Responsiveness and Minimal Clinically Important Difference of the Motor Function Measure in collagen VI-related dystrophies (COL6-RD) and laminin alpha2-related muscular dystrophy (LAMA2-RD) Type de document : Article Auteurs : Le Goff L ; Meilleur KG ; Norato G ; Rippert P ; Jain M ; Fink M ; Foley AR ; Waite M ; Donkervoort S ; Bonnemann CG ; Vuillerot C Editeur : United States Année de publication : 06/11/2020 Langues : Anglais (eng) Pubmed / DOI : Pubmed : 33166523 / DOI : 10.1016/j.apmr.2020.10.116
N° Profil MNM : 2020112 En ligne : http://www.ncbi.nlm.nih.gov/pubmed/33166523 Avis des lecteurs Aucun avis, ajoutez le vôtre !
(mauvais) 15 (excellent)
![]()
Effects of nusinersen after one year of treatment in 123 children with SMA type 1 or 2: a French real-life observational study
Audic F, De la Banda MGG, Bernoux D, et al.
Orphanet journal of rare diseases, 2020, 15, 1, p 148
Revue : Orphanet journal of rare diseases, 15, 1 Titre : Effects of nusinersen after one year of treatment in 123 children with SMA type 1 or 2: a French real-life observational study Type de document : Article Auteurs : Audic F ; De la Banda MGG ; Bernoux D ; Ramirez-Garcia P ; Durigneux J ; Barnerias C ; Isapof A ; Cuisset JM ; Cances C ; Richelme C ; Vuillerot C ; Laugel V ; Ropars J ; Altuzarra C ; Espil-Taris C ; Walther-Louvier U ; Sabouraud P ; Chouchane M ; Vanhulle C ; Trommsdorff V ; Perville A ; Testard H ; Lagrue E ; Sarret C ; Avice AL ; Beze-Beyrie P ; Pauly V ; Quijano-Roy S ; Chabrol B ; Desguerre I Année de publication : 06/2020 Pages : p 148 Langues : Anglais (eng) Pubmed / DOI : Pubmed : 32532349 / DOI : 10.1186/s13023-020-01414-8
N° Profil MNM : 2020061 En ligne : http://www.ncbi.nlm.nih.gov/pubmed/32532349 Avis des lecteurs Aucun avis, ajoutez le vôtre !
(mauvais) 15 (excellent)
![]()
Palliative Care in SMA Type 1: A Prospective Multicenter French Study Based on Parents' Reports
Hully M, Barnerias C, Chabalier D, et al.
Frontiers in pediatrics, 2020, 8, 4
Revue : Frontiers in pediatrics, 8 Titre : Palliative Care in SMA Type 1: A Prospective Multicenter French Study Based on Parents' Reports Type de document : Article Auteurs : Hully M, Auteur ; Barnerias C ; Chabalier D ; Le Guen S ; Germa V ; Deladriere E ; Vanhulle C ; Cuisset JM ; Chabrol B ; Cances C ; Vuillerot C ; Espil C ; Mayer M ; Nougues MC ; Sabouraud P ; Lefranc J ; Laugel V ; Rivier F ; Louvier UW ; Durigneux J ; Napuri S ; Sarret C ; Renouil M ; Masurel A ; Viallard ML ; Desguerre I Editeur : Switzerland Année de publication : 02/2020 Pages : 4 Langues : Anglais (eng) Pubmed / DOI : Pubmed : 32133329 / DOI : 10.3389/fped.2020.00004
N° Profil MNM : 2020031 En ligne : http://www.ncbi.nlm.nih.gov/pubmed/32133329 Voir aussiAvis des lecteurs Aucun avis, ajoutez le vôtre !
(mauvais) 15 (excellent)
![]()
Validity and Reliability of the 32-Item Motor Function Measure in 2- to 5-Year-Olds with Neuromuscular Disorders and 2- to 25-Year-Olds with Spinal Muscular Atrophy
Trundell D, Le Scouiller S, Gorni K, et al.
Neurology and therapy, 2020
Revue : Neurology and therapy Titre : Validity and Reliability of the 32-Item Motor Function Measure in 2- to 5-Year-Olds with Neuromuscular Disorders and 2- to 25-Year-Olds with Spinal Muscular Atrophy Type de document : Article Auteurs : Trundell D ; Le Scouiller S ; Gorni K ; Seabrook T ; Vuillerot C Editeur : New Zealand Année de publication : 2020 Langues : Anglais (eng) Pubmed / DOI : Pubmed : 32856191 / DOI : 10.1007/s40120-020-00206-3
N° Profil MNM : 2020091 En ligne : http://www.ncbi.nlm.nih.gov/pubmed/32856191 Voir aussiAvis des lecteurs Aucun avis, ajoutez le vôtre !
(mauvais) 15 (excellent)
![]()
Assessment of the validity and reliability of the 32-item Motor Function Measure in individuals with Type 2 or non-ambulant Type 3 spinal muscular atrophy
Trundell D, Trundell D, Le Scouiller S, et al.
PLoS ONE, 2020, 15, 9
Revue : PLoS ONE, 15, 9 Titre : Assessment of the validity and reliability of the 32-item Motor Function Measure in individuals with Type 2 or non-ambulant Type 3 spinal muscular atrophy Type de document : Article Auteurs : Trundell D ; Trundell D ; Le Scouiller S ; Le Goff L ; Gorni K ; Vuillerot C Année de publication : 2020 Langues : Anglais (eng) Pubmed / DOI : Pubmed : 32946459 / DOI : 10.1371/journal.pone.0238786
N° Profil MNM : 2020092 En ligne : http://www.ncbi.nlm.nih.gov/pubmed/32946459 Voir aussiAvis des lecteurs Aucun avis, ajoutez le vôtre !
(mauvais) 15 (excellent)
![]()
SMA - Des échelles d’évaluation motrice pour le public francophone : French adaptation of motor function scales for patients with spinal muscular atrophy
Pons C, Barrière A, Bertrand G, et al.
Les Cahiers de Myologie, 2019, 35, HS2, p 24
Permalink![]()
Cross-cultural Adaptation and Multi-centric Validation of the Motor Function Measure Chinese Version (MFM-32-CN) for Patients with Neuromuscular Diseases
Huang M, Cao J, Sun J, et al.
Developmental neurorehabilitation, 2019
Permalink![]()
Motor function performance in individuals with RYR1-related myopathies
Witherspoon JW, Vuillerot C, Vasavada RP, et al.
Muscle & Nerve, 2019, 60, 1, p 80
Permalink![]()
X-linked myotubular myopathy: A prospective international natural history study
Annoussamy M, Lilien C, Gidaro T, et al.
Neurology, 2019, 92, 16
Permalink![]()
Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Nagy S, Schmidt S, Hafner P, et al.
Journal of visualized experiments : JoVE, 2019, 143
Permalink![]()
Longitudinal changes in clinical outcome measures in COL6-related dystrophies and LAMA2-related dystrophies
Jain MS, Meilleur K, Kim E, et al.
Neurology, 2019, 93, 21
Permalink![]()
Nusinersen in patients older than 7 months with spinal muscular atrophy type 1: A cohort study.
Aragon-Gawinska K, Seferian AM, Daron A, et al.
Neurology, 2018, e1312
Permalink![]()
Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: Baseline data NatHis-SMA study.
Chabanon A, Seferian AM, Daron A, et al.
PLoS ONE, 2018, e0201004
Permalink![]()
Mathematical Disease Progression Modeling in Type 2/3 Spinal Muscular Atrophy
Jacqmin P, Jacqmin P, Gieschke R, et al.
Muscle & Nerve, 2018
Permalink![]()
Congenital titinopathy: Comprehensive characterisation and pathogenic insights
Oates EC, Jones KJ, Donkervoort S, et al.
Annals of neurology, 2018
Permalink![]()
Is Going Beyond Rasch Analysis Necessary to Assess the Construct Validity of a Motor Function Scale?
Guillot T, Roche S, Rippert P, et al.
Archives of physical medicine and rehabilitation, 2018
Permalink![]()
Corticosteroids in Duchenne muscular dystrophy: impact on the motor function measure sensitivity to change and implications for clinical trials
Schreiber A, Brochard S, Rippert P, et al.
Developmental medicine and child neurology, 2018, 60, 2, p 185
Permalink![]()
Minimal clinically important difference for the Motor Function Measure in patients with congenital muscular dystrophy and congenital myopathy : Abstract P326 extrait du colloque 23rd WMS Congress 2-6 october 2018 Argentina
Le Goff L, Fink M, Norato G, et al.
Neuromuscular disorders : NMD, 2018, 28
Permalink![]()
La juste mesure pour un meilleur accompagnement : Editorial
Vuillerot C, Poirot I
Les Cahiers de Myologie, 2017, 33, HS 1, p 5
Permalink![]()
Electrical impedance myography in individuals with collagen 6 and laminin alpha-2 congenital muscular dystrophy: a cross-sectional and 2-year analysis
Nichols C, Jain MS, Meilleur KG, et al.
Muscle & Nerve, 2017, 57, 1, p 54
Permalink![]()
First experience of Nusinersen early access program in patients with spinal muscular atrophy type 1
Gargaun E, Aragon-Gawinska K, Seferian A, et al.
Neuromuscular disorders : NMD, 2017, 27, s2, S211
Permalink![]()
Safety, tolerability and clinical efficacy of nusinersen in SMA type 1 older than 7 months: a prospective study
Aragon-Gawinska K, Gargaun E, Seferian A, et al.
Neuromuscular disorders : NMD, 2017, 27, s2, s211
Permalink![]()
Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trial
Bertini E, Dessaud E, Mercuri E, et al.
The Lancet. Neurology, 2017, 16, 7, p 513
Permalink![]()
2005-2015: Ten years clinical experience in treating DMD patients by corticosteroids in Lyon
Fontaine Carbonnel S, Rippert P, Poirot I, et al.
Annals of physical and rehabilitation medicine, 2016, 59S, p e82
Permalink![]()
Innovative method for motor functions evaluation in SMA type 2 and 3 patients
Vuillerot C, Vincent-Genod D, Thomann G, et al.
Annals of physical and rehabilitation medicine, 2016, 59S, p e84
Permalink